Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
about
Recent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian DescendantsComparison of two European models estimating risk of -sudden cardiac death in hypertrophic cardiomyopathy.Genetic Evaluation, Familial Screening and ExerciseOutcomes of an extended Morrow procedure without a concomitant mitral valve procedure for hypertrophic obstructive cardiomyopathyElectrophysiology Updates in Adult Congenital Heart Disease.The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy.Misclassification of hypertrophic cardiomyopathy: validation of diagnostic codes.Disopyramide for Hypertrophic Cardiomyopathy: A Pragmatic Reappraisal of an Old Drug.Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline.Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge.Is cardiac and hepatic iron status assessed by MRI T2* associated with left ventricular function in patients with idiopathic cardiomyopathy?Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders.Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy.Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal.Prognostic Significance of Plasma High-Sensitivity C-Reactive Protein in Patients With Hypertrophic Cardiomyopathy.Implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: an updated systematic review and meta-analysis of outcomes and complications.Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM)-rationale and design: a prospective observational study on incidence of arrhythmias in Sweden.Comparison of the Prognostic Usefulness of the European Society of Cardiology and American Heart Association/American College of Cardiology Foundation Risk Stratification Systems for Patients With Hypertrophic Cardiomyopathy.Patient understanding of disease and the use and outcome of implantable cardioverter defibrillators in hypertrophic cardiomyopathy.Hypertrophic Cardiomyopathy-Past, Present and Future.The athlete's heart is a proarrhythmic heart, and what that means for clinical decision making.Population Burden of Sudden Death Associated With Hypertrophic Cardiomyopathy.Relationship between left ventricular diastolic dyssynchrony and systolic dyssynchrony in hypertrophic cardiomyopathy by single-cardiac real-time three-dimensional ultrasonography.Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography.Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: What has Changed in The Guidelines?Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
P2860
Q28075331-60B4A907-E58B-4CA0-9074-66844C3B7EE5Q33168882-3B25F81C-5EF8-45D5-BE56-45AF5667D527Q33558953-C72417AB-1EA0-4547-8ABD-72155B605C32Q37054591-556D8B89-6388-4FA8-859E-323B5053C3DDQ37344566-01ED829D-12C9-4F44-BBE7-4B3ADDFBA802Q37596065-21865FA8-9F6D-4227-8906-B8D738131370Q38604979-724AFCD1-807E-448C-A71C-17C014420F71Q38673890-D33DDB21-668F-4D12-B33F-EA23D3E54547Q38863215-36F7C551-B976-492E-9EA7-B00BD7FC017AQ38884022-4F9795A3-BEB9-4662-AB91-5C30BCA33AD4Q38905476-36183FAD-20C0-4139-8B46-FF861CF212B4Q39050554-DCBF7DE7-0351-4495-A2CE-18FAC6DC758CQ40019666-642606EF-FC00-4F4E-9992-7EE5534AC042Q40492999-60717424-B709-484D-94B9-BF3E23DEDC3FQ41102423-D4DB7887-77E2-4E21-9134-B5B587174597Q41698112-F3D67718-8C77-4440-AA6C-C50E2DFE7C01Q42515078-618BB9A0-29FA-47C7-B503-97C118F8CBB2Q47132748-170636E1-056A-4CE6-A23A-5EB37510F4C6Q47371803-A09E4445-BF2C-4391-A8D2-408C328D0DE1Q47445769-B95BB44E-97E9-4E24-8AF5-D3CE086413B4Q47787101-F007D828-CF17-449F-9003-B4CCF5138438Q49825710-5BE4F61F-621A-43F1-8A87-21B2C0A1EC3AQ50072720-DE25AD6B-5C8C-4B93-AE60-64A45A5A1F94Q51732920-EF9EEA8B-2278-4D35-9BC7-AE3A5082035EQ52686171-22F79C6E-530D-4E21-B185-1D3C0170B079Q52955834-45DE9CF4-5478-4A43-BC29-431CC3E2DEAAQ53137860-58F74AE6-FF52-4ED7-A8E6-85F0BBEC95EBQ55427081-303562D7-BFBD-46C2-BB2A-876675BD89FBQ57298259-AED03F06-8777-461D-80E6-69B79618B98A
P2860
Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Hypertrophic Cardiomyopathy in ...... mporary Management Strategies.
@en
type
label
Hypertrophic Cardiomyopathy in ...... mporary Management Strategies.
@en
prefLabel
Hypertrophic Cardiomyopathy in ...... mporary Management Strategies.
@en
P2093
P1476
Hypertrophic Cardiomyopathy in ...... mporary Management Strategies.
@en
P2093
Barry J Maron
Ethan J Rowin
James E Udelson
John R Lesser
Mark S Link
Martin S Maron
Raymond H M Chan
Ross F Garberich
Susan A Casey
P304
P356
10.1016/J.JACC.2015.02.061
P407
P577
2015-05-01T00:00:00Z